Removing Healthy Ovaries In Premenopausal Women: No Sure Answers ...Medical News Today: 0 views since Wednesday, July 16, 2008 at 06:17 AMFor premenopausal women, the decision of whether to undergo a hysterectomy removal of the uterus is a challenging one. To make things more complex, added pressure to decide whether to remove the ovaries can arise a decision that researchers say relies more on the preferences of the woman or her surgeon than on evidence-based medicine.
Removing Healthy Ovaries in Premenopausal Women: No Sure Answers ...Newswise: 0 views since Tuesday, July 15, 2008 at 07:23 PMFor premenopausal women, the decision of whether to undergo a hysterectomy --removal of the uterus -- is a challenging one. To make things more complex, added pressure to decide whether to remove the ovaries can arise -- a decision that researchers say relies more on the preferences of the woman or her surgeon than on evidence-based medicine.
Theravance Announces Clinical Results in the LAMA Respiratory Program for the...Marketwire via Yahoo! Finance: 0 views since Monday, July 14, 2008 at 04:05 PMTheravance, Inc. today announced the results from a Phase 1 study designed to assess the safety, tolerability and pharmacokinetics of an investigational inhaled long-acting muscarinic antagonist, GSK1160724/TD-4208, for the treatment of chronic obstructive pulmonary disease.
Reading your blood ...Velo News: 0 views since Monday, July 14, 2008 at 06:50 AMWe live in an age of amazing technology. So amazing it is, in fact, that it takes much of the guesswork and mystery out of our daily lives, for an ever decreasing cost. Things that we may have never known about ourselves, like the regular status of our blood, can and should become a regular diagnostic routine. For athletes in general ? and endurance athletes in particular ? the status of the ...
Study to look at heart-lung bypass machine safety ...CTV.ca: 0 views since Friday, July 11, 2008 at 02:50 PMIt's a question that divides cardiac surgeons -- is it better and safer to perform bypass surgery with the patient on a heart-lung machine that stands in for the heart, or to do it on a pulsing organ still pumping blood to the body?
Omega-3 Fats Improve Brain Function ...The Epoch Times: 1 views since Thursday, July 10, 2008 at 11:14 PMPreviously, I have written about the potential benefits that omega-3 fats have regarding brain function. These fats appear to have not only antidepressant potential but also the capacity to help ma...
Study aims to find out whether using heart-lung machine during bypass is worse ...Cape Breton Post: 1 views since Thursday, July 10, 2008 at 08:00 PMTORONTO (CP) ? It?s a question that divides cardiac surgeons ? is it better and safer to perform bypass surgery with the patient on a heart-lung machine that stands in for the heart, or to do it on a pulsing organ still pumping blood to the body? For a number of years, a debate has raged about whether so-called on-pump or off-pump surgery produces better results and whether the latter reduces ...
Study aims to find out whether using heart-lung machine during bypass is worse ...The Canadian Press via Yahoo! Canada News: 1 views since Thursday, July 10, 2008 at 06:52 PMTORONTO - It's a question that divides cardiac surgeons - is it better and safer to perform bypass surgery with the patient on a heart-lung machine that stands in for the heart, or to do it on a pulsing organ still pumping blood to the body?
CardioNet: Charting its own course ...SmallCapInvestor.com via Yahoo! Finance: 1 views since Thursday, July 10, 2008 at 06:20 AMCardioNet Inc. has developed a real-time, outpatient heart monitor that's a quantum leap forward for the industry.
R) Reported To Be Safe And Effective In Study Published In European Journal Of...XclairMedical News Today: 1 views since Wednesday, July 9, 2008 at 08:23 AMALIGN Pharmaceuticals, LLC, a wholly owned subsidiary of Cyclacel Pharmaceuticals, Inc., (NASDAQ: CYCC, CYCCP) announced results of a double-blinded, randomized, vehicle-controlled clinical study showing that XclairŽ cream (formerly MAS065D) is safe and effective in the treatment and prevention of radiation dermatitis.
R)1 In Early Part ... ...Head-to-Head Study Demonstrates FocalinR XR Offers Faster And Better Symptom Control Than ConcertaMedical News Today: 1 views since Wednesday, July 9, 2008 at 06:05 AMA head-to-head study, published in the June Journal of Child and Adolescent Psychopharmacology, confirms that Focalin(R) XR (dexmethylphenidate HCl) extended-release capsules offer greater improvements in managing symptoms of Attention Deficit/Hyperactivity Disorder compared with Concerta(R)
Kaminsky and Ptacek comment on DNS flaw ...ZDNet: 1 views since Tuesday, July 8, 2008 at 09:09 PMWell, well, well, what a day for security news! I got a chance to get the scoop word of mouth from Dan Kaminsky of IOActive (pictured above [image courtesy of quinnums]) and Thomas Ptacek of Matasano pictured below on the DNS flaw that's been all over the...
Bereavement-Related Depression ...Psychiatric Times: 1 views since Tuesday, July 8, 2008 at 12:03 PMThe loss of a loved one is one of the most traumatic events in a person?s life. In spite of this, most people cope with the loss with minimal morbidity.
Screening for Cancer in Elderly Fuels Fight ...New York Times: 1 views since Monday, July 7, 2008 at 10:20 PMSo far, large clinical trials focused on the benefits of screening for breast cancer have ignored the booming population of elderly women.
R) Reported to Be Safe and Effective in Study Published in European Journal of...XclairCentre Daily Times: 1 views since Monday, July 7, 2008 at 09:35 AMALIGN Pharmaceuticals, LLC, a wholly owned subsidiary of Cyclacel Pharmaceuticals, Inc., (NASDAQ: CYCC, CYCCP) announced results of a double-blinded, randomized, vehicle-controlled clinical study showing that Xclair(R) cream (formerly MAS065D) is safe and effective in the treatment and prevention of radiation dermatitis. These results were published in the May-June 2008 issue of the European ...
R) Reported to Be Safe and Effective in Study Published in European Journal of...XclairBusiness Wire via Yahoo! Finance: 1 views since Monday, July 7, 2008 at 07:00 AMBERKELEY HEIGHTS, N.J.----ALIGN Pharmaceuticals, LLC, a wholly owned subsidiary of Cyclacel Pharmaceuticals, Inc., announced results of a double-blinded, randomized, vehicle-controlled clinical study showing that XclairŽ cream is safe and effective in the treatment and prevention of radiation dermatitis.
'Diablo 3' From the Top Down ...PC Magazine: 1 views since Wednesday, July 2, 2008 at 07:08 PMRob Pardo, a vice president at Blizzard, isn't just another suit. He's a gamer through and through, still actively playing many of his company's own games and even some others. We had a chance to sit down with Pardo and get his eagle's eye perspective on Diablo III.